Significance of ER―Src axis in hormonal therapy resistanceVALLABHANENI, Sreeram; NAIR, Binoj C; CORTEZ, Valerie et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 377-385, issn 0167-6806, 9 p.Article

Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanismsKRAVCHENKO, Julia; AKUSHEVICH, Igor; SEEWALDT, Victoria L et al.Breast cancer research and treatment. 2011, Vol 128, Num 2, pp 483-493, issn 0167-6806, 11 p.Article

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or youngerGAUDET, Mia M; PRESS, Michael F; HAILE, Robert W et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 587-597, issn 0167-6806, 11 p.Article

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cellsTHIRUCHELVAM, Paul T. R; LAI, Chun-Fui; SPIVEY, Alan C et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 385-396, issn 0167-6806, 12 p.Article

Expression of estrogen receptors in the hypothalamo-pituitary-ovarian axis in middle-aged rats after re-instatement of estrus cyclicityBÖTTNER, M; LEONHARDT, S; WUTTKE, W et al.Biogerontology (Dordrecht). 2010, Vol 11, Num 1, pp 75-85, issn 1389-5729, 11 p.Article